Komatsu, Y., Doi, T., Sawaki, A., Kanda, T., Yamada, Y., Kuss, I., . . . Nishida, T. (2015). Regorafenib for advanced gastrointestinal stromal tumors following imatinib and sunitinib treatment: A subgroup analysis evaluating Japanese patients in the phase III GRID trial. Int J Clin Oncol.
Styl ChicagoKomatsu, Yoshito, Toshihiko Doi, Akira Sawaki, Tatsuo Kanda, Yasuhide Yamada, Iris Kuss, George D. Demetri, a Toshirou Nishida. "Regorafenib for Advanced Gastrointestinal Stromal Tumors Following Imatinib and Sunitinib Treatment: A Subgroup Analysis Evaluating Japanese Patients in the Phase III GRID Trial." Int J Clin Oncol 2015.
Citace podle MLAKomatsu, Yoshito, et al. "Regorafenib for Advanced Gastrointestinal Stromal Tumors Following Imatinib and Sunitinib Treatment: A Subgroup Analysis Evaluating Japanese Patients in the Phase III GRID Trial." Int J Clin Oncol 2015.